There were 1,562 press releases posted in the last 24 hours and 413,435 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops

TO:
Mina Sooch, CEO
Ocuphire Pharma, Inc.
+1 248-681-9815

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image